Inhibition of receptor-interacting protein kinase 1 improves experimental non-alcoholic fatty liver disease

脂肪肝 坏死性下垂 脂肪性肝炎 脂肪变性 裂谷1 内分泌学 蛋白激酶A 程序性细胞死亡 生物 疾病 医学 内科学 化学 癌症研究 激酶 细胞生物学 生物化学 细胞凋亡
作者
Amine Majdi,Lynda Aoudjehane,Vlad Ratziu,Tawhidul Islam,Marta B. Afonso,Filoména Conti,Taïeb Mestiri,Marie Lagouge,Fabienne Foufelle,Florine Ballenghien,Tatiana Ledent,Marthe Moldes,Axelle Cadoret,Laura Fouassier,Jean-Louis Delaunay,Tounsia Aït‐Slimane,Gilles Courtois,Bruno Fève,Olivier Scatton,Carina Prip‐Buus
出处
期刊:Journal of Hepatology [Elsevier BV]
卷期号:72 (4): 627-635 被引量:156
标识
DOI:10.1016/j.jhep.2019.11.008
摘要

BACKGROUND & AIMS: In non-alcoholic fatty liver disease (NAFLD), hepatocytes can undergo necroptosis: a regulated form of necrotic cell death mediated by the receptor-interacting protein kinase (RIPK) 1. Herein, we assessed the potential for RIPK1 and its downstream effector mixed lineage kinase domain-like protein (MLKL) to act as therapeutic targets and markers of activity in NAFLD. METHODS: C57/BL6J-mice were fed a normal chow diet or a high-fat diet (HFD). The effect of RIPA-56, a highly specific inhibitor of RIPK1, was evaluated in HFD-fed mice and in primary human steatotic hepatocytes. RIPK1 and MLKL concentrations were measured in the serum of patients with NAFLD. RESULTS: When used as either a prophylactic or curative treatment for HFD-fed mice, RIPA-56 caused a downregulation of MLKL and a reduction of liver injury, inflammation and fibrosis, characteristic of non-alcoholic steatohepatitis (NASH), as well as of steatosis. This latter effect was reproduced by treating primary human steatotic hepatocytes with RIPA-56 or necrosulfonamide, a specific inhibitor of human MLKL, and by knockout (KO) of Mlkl in fat-loaded AML-12 mouse hepatocytes. Mlkl-KO led to activation of mitochondrial respiration and an increase in β-oxidation in steatotic hepatocytes. Along with decreased MLKL activation, Ripk3-KO mice exhibited increased activities of the liver mitochondrial respiratory chain complexes in experimental NASH. In patients with NAFLD, serum concentrations of RIPK1 and MLKL increased in correlation with activity. CONCLUSION: The inhibition of RIPK1 improves NASH features in HFD-fed mice and reverses steatosis via an MLKL-dependent mechanism that, at least partly, involves an increase in mitochondrial respiration. RIPK1 and MLKL are potential serum markers of activity and promising therapeutic targets in NAFLD. LAY SUMMARY: There are currently no pharmacological treatment options for non-alcoholic fatty liver disease (NAFLD), which is now the most frequent liver disease. Necroptosis is a regulated process of cell death that can occur in hepatocytes during NAFLD. Herein, we show that RIPK1, a gatekeeper of the necroptosis pathway that is activated in NAFLD, can be inhibited by RIPA-56 to reduce not only liver injury, inflammation and fibrosis, but also steatosis in experimental models. These results highlight the potential of RIPK1 as a therapeutic target in NAFLD.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
MY2720完成签到,获得积分10
3秒前
3秒前
4秒前
5秒前
5秒前
KYDD完成签到,获得积分10
5秒前
风吹麦浪的应助被laoying采纳,获得10
6秒前
刘亦然完成签到,获得积分10
6秒前
笨笨蜻蜓发布了新的文献求助10
7秒前
吴彦祖发布了新的文献求助20
7秒前
8秒前
星魂残月夜完成签到,获得积分10
8秒前
kasey发布了新的文献求助10
8秒前
小白完成签到 ,获得积分10
8秒前
怕孤单的若颜完成签到,获得积分10
9秒前
9秒前
9秒前
10秒前
邪恶大反派完成签到,获得积分10
10秒前
10秒前
cp完成签到,获得积分10
11秒前
黎1688关注了科研通微信公众号
11秒前
Jun的应助被初景采纳,获得10
12秒前
lishiyun完成签到,获得积分10
12秒前
姜露萍完成签到,获得积分10
12秒前
12秒前
keyIncy完成签到,获得积分10
12秒前
乐乐的应助被王安洋采纳,获得10
13秒前
科研通AI6.2的应助被Nan采纳,获得30
14秒前
14秒前
onlooker完成签到,获得积分10
14秒前
15秒前
15秒前
mm1314520发布了新的文献求助10
16秒前
非洲黑脸酋长完成签到 ,获得积分10
16秒前
认真碧灵完成签到,获得积分10
16秒前
小宋完成签到,获得积分20
17秒前
cube完成签到,获得积分10
17秒前
白白发布了新的文献求助10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8161320
求助须知:如何正确求助?哪些是违规求助? 9556074
关于积分的说明 21732157
捐赠科研通 7751456
什么是DOI,文献DOI怎么找? 3427537
关于科研通互助平台的介绍 2552583
邀请新用户注册赠送积分活动 2471992